Stock Research for SRDX

SRDX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SRDX Stock Chart & Research Data

The SRDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SRDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SRDX Due diligence Resources & Stock Charts

The SRDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SRDX Detailed Price Forecast - CNN Money CNN View SRDX Detailed Summary - Google Finance
Yahoo View SRDX Detailed Summary - Yahoo! Finance Zacks View SRDX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SRDX Trends & Analysis - Trade-Ideas Barrons View SRDX Major Holders - Barrons
NASDAQ View SRDX Call Transcripts - NASDAQ Seeking View SRDX Breaking News & Analysis - Seeking Alpha
Spotlight View SRDX Annual Report - CompanySpotlight.com OTC Report View SRDX OTC Short Report - OTCShortReport.com
TradeKing View SRDX Fundamentals - TradeKing Charts View SRDX SEC Filings - Bar Chart
WSJ View Historical Prices for SRDX - The WSJ Morningstar View Performance/Total Return for SRDX - Morningstar
MarketWatch View the Analyst Estimates for SRDX - MarketWatch CNBC View the Earnings History for SRDX - CNBC
StockMarketWatch View the SRDX Earnings - StockMarketWatch MacroAxis View SRDX Buy or Sell Recommendations - MacroAxis
Bullish View the SRDX Bullish Patterns - American Bulls Short Pains View SRDX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SRDX Stock Mentions - StockTwits PennyStocks View SRDX Stock Mentions - PennyStockTweets
Twitter View SRDX Stock Mentions - Twitter Invest Hub View SRDX Investment Forum News - Investor Hub
Yahoo View SRDX Stock Mentions - Yahoo! Message Board Seeking Alpha View SRDX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for SRDX - SECform4.com Insider Cow View Insider Transactions for SRDX - Insider Cow
CNBC View SRDX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SRDX - OTC Markets
Yahoo View Insider Transactions for SRDX - Yahoo! Finance NASDAQ View Institutional Holdings for SRDX - NASDAQ


Stock Charts

FinViz View SRDX Stock Insight & Charts - FinViz.com StockCharts View SRDX Investment Charts - StockCharts.com
BarChart View SRDX Stock Overview & Charts - BarChart Trading View View SRDX User Generated Charts - Trading View


Latest Financial News for SRDX

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer
Posted on Wednesday May 16, 2018

EAGAN, Minn., May 16, 2018-- Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29. Biothera Pharmaceuticals ...


Surmodics Announces Leadership Change and Appointment of Interim CFO
Posted on Wednesday May 16, 2018

Surmodics, Inc. (SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today Andrew LaFrence will resign as Chief Financial Officer (CFO) effective May 25, 2018. Following LaFrence’s departure, Timothy J. Arens, Vice President of Corporate Development and Strategy, will serve as interim CFO. “We greatly appreciate the contributions Andy has made during his tenure at Surmodics and wish him the best in his future endeavors,” said Gary Maharaj, President and Chief Executive Officer of Surmodics.


Surmodics (SRDX) Hits a 52-Week High, Can the Run Continue?
Posted on Tuesday May 15, 2018

Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.


Surmodics Acquires Thrombectomy Technology Assets from Embolitech, Strengthening Peripheral Vascular Whole-Product Solutions Portfolio
Posted on Monday May 14, 2018

Surmodics, Inc. (SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today it has reached an agreement with Embolitech to acquire an innovative thrombectomy platform technology and related intellectual property with broad potential peripheral vascular applications. Under the agreement, Surmodics will pay $5 million up front, and additional amounts related to various regulatory milestones. The addition of this technology to the Surmodics peripheral vascular pipeline strengthens the company’s focus on developing highly differentiated whole-product solutions for its medical device customers.


Enter a stock symbol to view the stock details.